12772437

Source:http://linkedlifedata.com/resource/pubmed/id/12772437

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003601, umls-concept:C0007222, umls-concept:C0016441, umls-concept:C0023820, umls-concept:C0030705, umls-concept:C0032105, umls-concept:C0332307
pubmed:issue	1
pubmed:dateCreated	2003-5-29
pubmed:abstractText	To evaluate the role of lipoprotein abnormalities as risk factors for macroangiopathy in Type 2 diabetes.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9111474
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-II, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein C-II, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein C-III, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins C, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E, http://linkedlifedata.com/resource/pubmed/chemical/Apoproteins, http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0939-4753
pubmed:author	pubmed-author:CrepaldiGG, pubmed-author:FedeleDD, pubmed-author:LapollaAA, pubmed-author:ManzatoEE, pubmed-author:MinicuciNN, pubmed-author:Roselli della RovereGG, pubmed-author:RossettiCC, pubmed-author:SartoriCC, pubmed-author:ZambonSS
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	46-51
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:12772437-Age Factors, pubmed-meshheading:12772437-Aged, pubmed-meshheading:12772437-Apolipoprotein A-II, pubmed-meshheading:12772437-Apolipoprotein C-II, pubmed-meshheading:12772437-Apolipoprotein C-III, pubmed-meshheading:12772437-Apolipoproteins C, pubmed-meshheading:12772437-Apolipoproteins E, pubmed-meshheading:12772437-Apoproteins, pubmed-meshheading:12772437-C-Peptide, pubmed-meshheading:12772437-Cardiovascular Diseases, pubmed-meshheading:12772437-Cerebrovascular Disorders, pubmed-meshheading:12772437-Coronary Disease, pubmed-meshheading:12772437-Diabetes Mellitus, Type 2, pubmed-meshheading:12772437-Fasting, pubmed-meshheading:12772437-Female, pubmed-meshheading:12772437-Follow-Up Studies, pubmed-meshheading:12772437-Hemoglobin A, Glycosylated, pubmed-meshheading:12772437-Humans, pubmed-meshheading:12772437-Lipoproteins, pubmed-meshheading:12772437-Male, pubmed-meshheading:12772437-Middle Aged, pubmed-meshheading:12772437-Prospective Studies, pubmed-meshheading:12772437-Risk Factors, pubmed-meshheading:12772437-Smoking
pubmed:year	2003
pubmed:articleTitle	Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.
pubmed:affiliation	Department of Medical and Surgical Sciences, University of Padova, Padova, Italy.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't